Market News How it works Learn FAQ
| RCT 0.1382 81.60% | NU 11.97 -21.04% | TGL 0.2617 18.15% | EWZ 32.715 -23.19% | SRTM 0.3394 -21.12% | BBD 2.835 -30.34% | SHFS 0.0989 -25.30% | GCDT 0.1322 -24.93% | ITUB 7.368 -23.81% | NWGL 0.0817 -0.37% | CLRO 4.67 43.69% | XP 14.8623 -51.13% | AZTR 1.265 76.92% | RBNE 0.1664 -12.42% | PBR 21.535 -17.68% | SGRY 23.055 46.38% | SOXL 85.96 2.87% | TSLL 10.8899 11.58% | SPCX 147.535 0.03% | VALE 12.0045 -3.19% | SPRC 1.4499 33.02% | NVD 4.04 -3.58% | CRWV 54.96 1.34% | JBLU 2.2085 -15.87% | SOXS 51.01 -2.76% | INTC 87.29 0.38% | GPUS 0.1679 -0.59% | NVDA 215 1.92% | TSLA 394.1 5.88% | IREN 24.64 -1.06% | ABEV 2.7991 -15.18% | TQQQ 67.83 2.32% | RENT 2.9899 30.00% | NOK 8.46 3.93% | INTR 4.415 -38.60% | PBR-A 18.92 -19.59% | XTND 2.8083 58.66% | SQQQ 38.76 -2.32% | BITO 10.6402 -1.75% | LUCD 0.5437 32.29% | SPDN 8.495 -0.53% | VBIO 0.8098 -13.85% | SBS 4.765 -25.55% | XXII 0.0999 -49.47% | SID 0.9233 -21.75% | STNE 7.96 -30.66% | KORU 10.6 0.19% | WFF 0.0765 -4.38% | RWM 14.4501 -0.69% | TSLG 5.45 11.91%
CBCibus, Inc. logo

Cibus, Inc. (CBUS)

NASDAQ · Currency in USD
$1.41 ▲ +0.00 (+0.00%)
As of Oct 26, 10:54 AM ET. Market open.

Summary

Previous Close
$1.41
Open
$1.42
Day's Range
$1.40 – $1.42
52 Week Range
$1.09 – $4.19
Volume
16,628
Avg. Volume
241,667
Market Cap
$107.76M
Beta (5Y Monthly)
1.57
PE Ratio (TTM)
--
EPS (TTM)
-$1.28
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$11.50

Profile: Cibus, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
118
CEO
Craig Wichner
Website
cibus.com

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$0.20 · Revenue est. $1.30M
DateEst.Actual
Aug 13, 2026-$0.19-$0.29Miss
May 14, 2026-$0.35-$0.33Beat
Mar 17, 2026-$0.43-$0.42Beat
Nov 13, 2025-$0.41-$0.44Miss
Aug 14, 2025-$0.69-$0.61Beat
May 8, 2025-$0.70-$1.34Miss

Analyst view

Consensus price target
$11.50 ▲ +715.6%
Range $10.50 – $12.50
Rating: Buy
Buy 75% · Hold 25% · Sell 0%

Get free alerts on CBUS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.